Skip to content
MedGadget – Medical Technology and Healthcare News Website Logo

MedGadget

Where Medicine Meets Technology

  • Author
  • Contact Us
  • About Us
Top Stories
Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines
Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines
Bristol Myers Squibb Q3 2026 results graphic about pipeline data
Posted inPharmaceutical

Bristol Myers Squibb Q3 2026 Results: What the Pipeline Data on CELMoDs and Admilparant Show

The Bristol Myers Squibb Q3 2026 results include CELMoD, admilparant and RYZ101 updates. What each result shows and what is pending.
Continue Reading
October 30, 2026
Laurus Labs Galenvs acquisition graphic about oligonucleotide technology
Posted inBio Technology

Laurus Labs Galenvs Acquisition: The Oligonucleotide and Nanoparticle Technology Behind the Deal

The Laurus Labs Galenvs acquisition buys oligonucleotide and nanoparticle skills. What the technology involves and what is not shown.
Continue Reading
October 30, 2026
Fortis Healthcare acquisition graphic about care quality in Bengaluru
Posted inHealthcare Services

Fortis Healthcare Acquisition of Suguna Hospital: What Consolidation Means for Care Quality in Bengaluru

The Fortis Healthcare acquisition adds 110 beds in north-west Bengaluru. What evidence says about hospital deals and quality.
Continue Reading
October 30, 2026
Top Categories
Healthcare IT
Healthcare IT
Medical Device
Medical Device
Pharmaceutical
Pharmaceutical
Molecular Partners workforce reduction 2026 graphic about targeted radiotherapeutics
Posted inBio Technology

Molecular Partners Workforce Reduction 2026: How Targeted Radiotherapeutics Work

The Molecular Partners workforce reduction 2026 refocuses a biotech on radio-DARPins. How targeted radiation drugs work and where candidates stand.
October 30, 2026
Geron IMpactMF trial discontinued graphic explaining a Phase 3 futility decision
Posted inBio Technology

Geron IMpactMF Trial Discontinued: What a Futility Call Means in Myelofibrosis

What the Geron IMpactMF trial discontinued decision means: how monitoring committees work, what futility is and what is still unknown.
October 30, 2026
Biogen Q3 2026 results graphic about portfolio and pipeline
Posted inPharmaceutical

Biogen Q3 2026 Results: Which Medicines Drove Growth and What the Pipeline Holds

The Biogen Q3 2026 results by product: growth drivers, the declining MS franchise and the Phase 3 readouts that could matter next.
October 29, 2026
Nucelion Pandorum partnership graphic about cell-free exosome eye research
Posted inLife Science

Nucelion Pandorum Partnership: How Cell-Free Exosome Eye Therapies Are Made

The Nucelion Pandorum partnership pairs a cell-free eye-therapy developer with a GMP manufacturer. What exosomes are and what is unproven.
October 29, 2026
Vera Health Series A funding graphic about evidence-graded clinical AI search
Posted inHealthcare IT

Vera Health Series A Funding: How Evidence-Graded Clinical AI Search Works

The Vera Health Series A funding highlights evidence-graded clinical AI search. How it differs from a chatbot, and what to ask of any such tool.
October 29, 2026
UK GP websites outage October 2026 patient guide graphic
Posted inHealthcare IT

UK GP Websites Outage October 2026: What Patients Should Do

A guide to the UK GP websites outage October 2026: how to contact your surgery, request repeat prescriptions and get urgent help.
October 29, 2026
India cancer medicine price revision 2026 patient guide graphic
Posted inPharmaceutical

India Cancer Medicine Price Revision 2026: What Patients Should Check From November 9

A guide to the India cancer medicine price revision 2026: how the NPPA list works, how to check your medicine, and what is still unclear.
October 29, 2026
Mylan telmisartan amlodipine recall graphic explaining FDA recall classes
Posted inPharmaceutical

Mylan Telmisartan Amlodipine Recall: What a Class III Drug Recall Means

What the Mylan telmisartan amlodipine recall means: Class III, superpotent tablets, five lots, and how to read an FDA recall notice.
October 28, 2026
SCHOTT Pharma India name change graphic about glass syringes and injectable packaging
Posted inPharmaceutical

SCHOTT Pharma India Name Change: Glass Syringes and Injectable Packaging in Focus

The SCHOTT Pharma India name change puts glass pre-fillable syringes and injectable packaging in focus. What the company makes and what is undisclosed.
October 28, 2026
Indoco Remedies AnaCipher ANVISA approval graphic explaining bioequivalence studies
Posted inPharmaceutical

Indoco Remedies AnaCipher ANVISA Approval: Why Bioequivalence Sites Are Inspected

What the Indoco Remedies AnaCipher ANVISA approval means for bioequivalence studies, and why regulators inspect clinical and bioanalytical sites.
October 28, 2026

Posts pagination

Previous page 1 2 3 4 … 25 Next page

All Categories

  • Bio Technology
  • Healthcare IT
  • Healthcare Services
  • Life Science
  • Medical Device
  • Pharmaceutical
  • Press Releases
  • Uncategorized
Press Releases
Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines
Posted inPress Releases

Vetter Expands Commercial Fill-and-Finish Capacity with Ten New Manufacturing Lines

Firefly Neuroscience and NeuroSigma Expand Access to Non-Drug Pediatric ADHD Treatment
Posted inPress Releases

Firefly Neuroscience and NeuroSigma Expand Access to Non-Drug Pediatric ADHD Treatment

InSilicoTrials Joins ARPA-H CIRCLE Program to Advance Digital Health Through Critical Care Digital Twins
Posted inPress Releases

InSilicoTrials Joins ARPA-H CIRCLE Program to Advance Digital Health Through Critical Care Digital Twins

Grünenthal and DKSH Expand Pain Medicine Partnership Across Eight Asia-Pacific Markets
Posted inPress Releases

Grünenthal and DKSH Expand Pain Medicine Partnership Across Eight Asia-Pacific Markets

Copyright 2026 — MedGadget.
Scroll to Top